Earnings Labs

Innovative Industrial Properties, Inc. (IIPR)

Q3 2019 Earnings Call· Thu, Nov 7, 2019

$55.77

+0.02%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.

Same-Day

+6.75%

1 Week

+3.41%

1 Month

-7.18%

vs S&P

-8.91%

Transcript

Operator

Operator

Good day, and welcome to the Innovative Industrial Properties, Inc. Third Quarter 2019 Earnings Conference Call and Webcast. [Operator Instructions]. Please note this event is being recorded. I would now like to turn the conference over to Mr. Brian Wolfe, General Counsel. Mr. Wolf, the floor is yours, sir.

Brian Wolfe

Analyst

Thank you for joining the call. Presenting today are Alan Gold, Executive Chairman; Paul Smithers, President and Chief Executive Officer; Catherine Hastings, Chief Financial Officer; and Ben Regin, Director of Investments. Before we begin, I'd like to remind everyone that statements made during today's conference call may be deemed forward-looking statements within the meaning of the safe harbor of the Private Securities Litigation Reform Act of 1995, and actual results may differ materially due to a variety of risks, uncertainties and other factors.For a detailed discussion of some of the ongoing risks and uncertainties of the company's business, I refer you to the news release issued yesterday and filed with the SEC on Form 8-K as well as the company's reports filed periodically with the SEC. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.Before I hand the call over to Alan, I want to mention that we have limited time for the call today, but we will answer as many questions as we can after our prepared remarks. Alan?

Alan Gold

Analyst

Thank you, Brian, and welcome, everyone. Today, based on the exciting third quarter and subsequent to the quarter acquisition activity, we have chosen to host a call today to share our financial results for the third quarter plus year-to-date 2019 and provide our updated perspective on the business and the industry from our most recent call in August. Now into our third year of operations. The momentum of our business has been tremendous. To recap briefly, in 2019 year-to-date, we acquired 30 properties in 9 states and amended leases with our existing tenants for additional property improvements, collectively representing over $380 million of investments, which included both follow-on transactions with our existing tenant partners to facilitate their continued expansion and new tenant relationships.Ben Regin, our Director of Investments will discuss our recent acquisitions in more detail and overall portfolio, including the addition of several top-performing, multistate operators in the industry.As of today, we own 41 properties in 13 states, totaling 2.8 million square feet, which are 100% leased on a long-term basis to high-quality, licensed cannabis operators. Our current blended yield on these properties is 13.8%, with a weighted average remaining lease term of 15.5 years. In addition, we paid a quarterly stock dividend of $0.78 per share to stockholders on October 15th, representing a 123% increase over our third quarter 2018 dividend and a testament to our property portfolio's operating performance and confidence in our pipeline of acquisitions.This dividend was also supported by our tremendous 200% plus growth year-over-year in rental revenue, net income and AFFO, which to note, does not take into account at all the 10 acquisitions we completed after quarter end, constituting over $150 million of additional investments. Catherine will also provide more detail regarding our financial results. The medical-use cannabis industry continues to experience tremendous growth and change, and Paul will provide some detail on industry and regulatory trends in our call today. Finally, as announced earlier this week, we continue to make great additions to our team, most recently with the appointment of Tracie Hager as Vice President, Asset Management; and Kelly Spicher as Senior Real Estate Counsel. Tracie brings nearly 3 decades of leadership in institutional property management and Kelly with over 16 years of experience advising clients on a variety of complex real estate matters. We are thrilled to have them join the IIP team. We continue to be very optimistic about the future of this nascent industry and our ability to deliver results for our stakeholders and enduring value to our tenant partners by providing tailored real estate solutions that meet key operational and capital needs.With that, I'd like to turn the call over to Paul. Paul?

Paul Smithers

Analyst

Thanks, Alan. As with prior calls, we'll try to provide as an effective an overview as we can with the short time we have today, focusing in on 2 main topics: one, the current regulatory environment, and two, the dynamics of the industry and developments that we continue to monitor closely. First, regarding the current federal regulatory environment and legislative developments. Of course, cannabis remains a Schedule I controlled substance, which generally prohibits all cannabis use and cannabis-related commercial activity in the United States. That said, Congress has continued to enact spending bills since 2014 with a provision that has been interpreted by courts as preventing the Department of Justice from using funds to interfere with the implementation of state medical-use cannabis laws. That provision was again included in this year's congressional spending bill passed earlier this year, which carries through to November 21st of this year as part of the stop gap spending bill passed on September 27. Importantly, the Senate Appropriations Committee has also approved this provision again for the fiscal year 2020 spending bill in late September.As we reported earlier in June, the house voted 267 to 165 to approve a broader provision that would have included these protections for the regulated adult-use cannabis programs as well. But the Senate Appropriations Committee did not include similar language in its proposed legislation. As a result, the provision protecting medical-use cannabis programs is expected to continue as it has since 2014, but will not include the additional similar protection for states, adult-use cannabis programs. In addition, as I am sure you're all aware, the Secure and Fair Enforcement Banking Act, also known as the SAFE Banking Act, was passed by the house in late September with resounding support in a vote of 321 to 103. The legislation now moves…

Ben Regin

Analyst

Thanks, Paul. The last 4 months, July through October, have been by far the busiest four months in our company's history in terms of acquisition activity. Since July 1st, we have acquired 20 properties in 8 states and executed 4 lease amendments with tenants at existing properties as they continue to build additional capacity to meet the demand for their products. As of today, we own 41 properties across 13 states, representing approximately 2.8 million square feet, including approximately 903,000 square feet under development or redevelopment. I plan to touch on each of our acquisitions by state and also provide some information about each tenant and our portfolio overall in the state.Starting with Illinois. We were very active over the last 4 months, originally entering the state with our acquisition and leased to Ascend Wellness late last year. In September, we amended our lease with Ascend to provide an additional $8 million for tenant improvements at the property, which resulted in a corresponding adjustment to base rents and is expected to significantly increase production capacity at the property.Ascend is a vertically integrated multistate operator that has raised over $100 million in capital to date. In October, we acquired two more properties in Illinois totaling 90,000 square feet of industrial space and entered into long-term leases for each property with Cresco Labs, with our total investment in the acquisition and tenant improvements at the properties expected to be $46.6 million in the aggregate. Cresco Labs was founded in 2013 and is one of the largest vertically integrated companies in the United States with licensed operations in 9 states and pending transactions in 3 states. Including its pending acquisitions, Cresco has 23 licensed cannabis production facilities, 66 retail cannabis licenses and 34 operational cannabis dispensaries.Also in October, we acquired a 70,000 square…

Catherine Hastings

Analyst

Thanks, Ben. It has been a busy quarter, which is reflected in our financial results for the third quarter and 9 months year-to-date. We generated rental revenues of approximately $11.2 million and $26.1 million for the 3 and 9 months ended September 30, 2019, respectively. The increases in both periods were driven primarily by the acquisition and leasing of new properties, additional tenant improvement allowances provided to tenants at certain properties that resulted in base rent adjustments and contractual rent escalations at certain properties.Importantly, this revenue growth reflects only partial quarters of revenues from the numerous acquisitions and leases executed during the year. And no revenue, of course, from the 10 leases we executed after the end of the quarter. Our revenues for the quarter were also impacted by rent abatements or deferrals under certain leases that are expected to burn off in the next few months as we continue to account for all of our leases on a cash basis. Notwithstanding all of this, our Q3 rental revenues more than tripled year-over-year from Q3 of 2018.For the three months ended September 30, 2019, we recorded net income of $6.2 million, funds from operations, which adds back property depreciation to net income was $8.4 million. Adjusted funds from operations, which adds back noncash, stock-based compensation expense and noncash interest expense related to our exchangeable senior notes was $9.5 million. For the 3 months ended September 30, 2019, adjusted funds from operations for Q3 grew 270% from the prior period.For the 9 months ended September 30, 2019, we recorded net income of $12.6 million, funds from operations of $17.6 million, and adjusted funds from operations of $20.6 million. For the 9 months ended September 30, 2019, adjusted funds from operations increased by 238% from the prior period.As Alan mentioned, on October 15th, we paid our quarterly dividend of $0.78 per share to common stockholders of record as of September 30th. The Q3 2019 common stock dividend reflects a 30% increase from the prior quarter and a 123% increase from the prior year's third quarter. This serves as a reflection of our strong growth and operational performance over the past year and our confidence in our acquisition pipeline, including the post-September 30th acquisitions completed that Ben discussed earlier.And with respect to financing activity, in July 2019, we completed a follow-on public offering of common stock, raising net proceeds of about $180 million, including the exercise in full of our underwriters' option to purchase additional shares. In September 2019, we established an aftermarket equity offering program or ATM program with 3 sales agents and raised net proceeds under the program in September and October of about $47 million. We are truly grateful for all of our stakeholders' continued support, and we are focused exclusively on investing the proceeds from our recent equity raises with the best tenants. And with that, I'll turn it back to Alan. Alan?

Alan Gold

Analyst

Thanks, Catherine. We've had a tremendous year-to-date for acquisitions, far outpacing our expectations. With that, we are very excited about the opportunities to come in this fast-growing industry and are singularly focused on executing our business plan. I want to personally thank our stockholders for your continued support as we aim to continue to create sustainable and long-term value for you.With that, I'd like to open it up to questions.Operator, could you please open the call up for questions.

Operator

Operator

[Operator Instructions]. And the first question we have will come from Tom Catherwood of BTIG.

William Catherwood

Analyst

When it comes to investment yields, it seems like recently, there's been a wider dispersion than normal with Trulieve and Cresco, both larger operators around 11% and then some of the more recent yields are closer to your blended average. Have you changed your underwriting in terms of investment hurdle rates? And kind of what are your expectations for investment yields over the next 9 to 12 months?

Alan Gold

Analyst

Sure. Yes, that was a great question, Tom. First, the normal, I guess, it's hard to say what's normal, given how fast the industry is growing and how relatively nascent the industry is and the fact that we've only been in the acquisition market doing these sale-leaseback transactions over the last 3 years. But yes, you have seen a greater dispersion in acquisition yields going all the way down to an 11% for some of the most highest quality growers and that's done on purpose. We focused on increasing our -- the quality and the size and the number of the top name growers in the industry on purpose. And have added those -- several of those players to -- or those growers to our tenant roster, which we're very excited about. It's a very strong roster. The -- where we are today, we are seeing increased acquisition yields, higher acquisition yields than we saw even as of mid last year or early this year. And we are now projecting our acquisition yields to be ranging anywhere from 12% to north of 15%, and that's a 100 to 200 basis points increase in our acquisition yields just in the most recent time period.

William Catherwood

Analyst

Got it. I appreciate that. And then this might not be the right way to think of it. But when it comes to investment opportunities, do you have a sense of the aggregate volume that you typically underwrite, and of that kind of how much do you tend to pursue? And then what's your hit rate been on what you tend to pursue? Is that even a proper way to think about it for your business?

Alan Gold

Analyst

I guess, I could have been, perhaps go down that path. But keeping in mind that we focus on a -- our tenant growers -- our tenant roster. And as you can see from the acquisitions, probably over 75% of our most recent acquisitions are actually repeat business with our existing growers. And if -- I think, Ben, if we talked about our pipeline, you would say, what percentage is with the existing growers today?

Ben Regin

Analyst

Yes. I'd say going forward, it's anywhere from 50% to 75% depending on the pipeline at the time.

Alan Gold

Analyst

Right. So given the fact that we've already underwritten these growers, and we're highly focused on being a very strong capital partner for these growers. We see -- we tend to be -- we tend to move forward on a greater percentage with those growers. Although I do know that some of the growers have proposed some transactions that just haven't recently fit our new acquisition yields and have chosen to go with other capital providers. On top of that, perhaps more directly to answer your question, we have -- we do consistently receive a lot of inquiries from growers that just aren't in the -- don't fit our underwriting criteria today. We do stay in contact with them as they continue to move forward on their business plan. And then hopefully, they get large enough to become part of our tenant roster at some point in the future.

William Catherwood

Analyst

Got it. It makes a lot of sense. And then I appreciate the color on DionyMed. Moving beyond them, though, are there any other of your tenants that you have on any kind of a watch list? And what kind of steps would you take? Or could you even take if you had a challenged tenant?

Alan Gold

Analyst

Well, we watch all of our tenants, we are.

William Catherwood

Analyst

Very fair.

Alan Gold

Analyst

And we do believe that this is still a nascent industry, and there is still a lot of moving things -- moving parts going on in the industry. There isn't any single tenant right now that we're watching more closely than any other tenant. Obviously, we are in direct contact with DionyMed and looking to see how the receivership process is going to play out with them. We think it's -- we think that -- we've underwritten that asset correctly. We think that, that asset has tremendous long-term value. We think that -- we've been contacted by several other MSOs who are -- have indicated interest because -- interest in the site, given that they -- given how public the issues that DionyMed is going through. So then, when we underwrite, we absolutely look for MSOs with multi -- with a lot of operations. We think that the assets themselves, given the fact that they are closely tied or linked to licenses have tremendous value. And it's obviously proving out in the DionyMed situation.So we think that -- should we end up in that situation, one, we have security deposits that we could use and draw down on should we need them. Two, we believe the growers themselves have -- or have cash balances and will support the most valuable, most mission-critical aspect of their business, which is their grow facilities, or their ability to generate revenue from. Three, the licenses are tied to it, creating a tremendous value to the real estate itself. And four, the industry is continuing to grow. And there are -- I mean, the year-over-year growth rate of sales in the industry is still exceeding the -- or approaching the 30-plus percent year-over-year in sales that we've seen over the last several years. And so we believe that there are a tremendous number of growers that are interested -- or people interested in getting into the business and all of those become factors that help protect the value of the asset and the longevity of the cash flow that we anticipate.

William Catherwood

Analyst

Got it. I appreciate the background color, Alan. And then last one for me. Ben you had mentioned the Trulieve facility in Massachusetts. So I think they have until the end of January to finalize their plans, pricing and decide kind of what kind of budget they're looking for and what your reimbursement is. Do you have any kind of sense on timeline there? Is it going to happen before January? Is it something we might see this year? Or should we just -- is that a 2020 event?

Alan Gold

Analyst

Yes, thanks, Tom. I think that's likely to be in 2020. We're remaining in close contact with Trulieve and working with them as they continue to finalize their plans and their budget for their facility, and we'll support them on the amount that's ultimately needed for the build-out of the property.

Operator

Operator

Next, we have John Massocca of Ladenburg Thalman.

John Massocca

Analyst

John. So just following up on that last question, maybe a little bit more philosophically, as you think about the potential funding you have out there for tenants that can kind of draw down that capital at their choice, how do you think about matching that with kind of cash on hand. I mean is that something where given you have the ATM in place today, you can kind of match that at the time of the draw? Or is it much like some of the stuff where you've kind of committed to TI dollars that you know the tenant kind of has to take, the tenant is going to pay rent for anyway. Even though that cash hasn't gone out the door today, you still want to have it on hand given the fact that you don't have access to a credit facility or something like that. So is it similar to that type of money? Or is it something where you feel you can fund that later when you get the actual decision from the tenant?

Alan Gold

Analyst

Well, certainly, all those options are available to us to consider and think through. And I'm going to have Cat kind of run through where we are on a cash basis just so that -- so that's clear. But the -- when we make a commitment to our tenant growers, we're making a commitment and that -- and the capital needs to be available for them based on that commitment. There's -- these aren't -- it's not at our option to provide it. If they desire it and demand it, we need to make sure that we have it available for them. So we take those commitments extremely seriously and retain cash on our balance sheet for that -- for those commitments. But Cat, why don't you go through where we are -- where we stand on a cash basis today.

Catherine Hastings

Analyst

Yes, John, I think what Alan said is extremely important. I mean that's one of our big differentiators, I think, between us and the other players out there who are doing what we're doing is that we have capital available and when we've committed it to those operators, we make sure that we have it raised and held in reserve. We do monitor the construction and the development plans of the various operators and understand kind of timing of when they're actually going to be requesting those draws and so that also enables us to understand that timeline of when that cash needs to be available and paid out to them. And that's why you do see the large $140 million commitment that is unfunded to date. And we do manage that with the cash that we have on balance sheet as well.So if you look at what we've raised to date with capital and including the ATM proceeds, we've raised about $634 million to date and have funded $410 million of that with unfunded commitments of about $140 million.

John Massocca

Analyst

And the unfunded commitments, does that include the stuff that's at the tenant's option such as Trulieve and one of the PharmaCann assets?

Catherine Hastings

Analyst

No. We've excluded that since they have the ability to turn a portion of that back.

John Massocca

Analyst

So if you include all of that, let's say, that's fully executed, where would that leave you versus kind of cash today.

Catherine Hastings

Analyst

We're at about $20 million to $30 million of cash today. We're extremely happy to have the additional capacity on that ATM to continue to grow with our growing pipeline that we have as well. We also are very happy to have other options like the common follow-on raises as well as the convertible debt options because we see incredible opportunity to continue to raise capital and be able to place it. I think when we did the July common raise, we said we wanted to be able to place that capital that we raised within 6 to 9 months. And you can see from the pace of the acquisitions that we have been ahead of that pace.

John Massocca

Analyst

Okay, that makes sense. And then switching gears a little bit. Given you completed your first dispensary acquisitions in Q3 '19, Q4 '19, what is the opportunity to complete more transactions for dispenser real estate and what made the retail assets you did buy attractive?

Alan Gold

Analyst

So we've always indicated that we would look at a portfolio of retail-type assets with a strong grower. And we believe that we continue to go down the path of supporting our growers and their capital needs when appropriate and the opportunity to work with Green Peak Industries for -- in Michigan with their -- for their dispensaries made sense for us. The -- we think supporting Green Peak and their ability to generate tremendous amount of revenues from a very exciting Michigan market was appropriate. Keeping in mind that we aren't interested in one-off type transactions with -- on retail dispensaries, just given the size and the complexity of underwriting any transaction, let alone a small retail-located transaction.

John Massocca

Analyst

Very helpful color. And then what kind of -- was there anything specific do you think that drove some of these lease amendments to kind of give additional funding to like existing properties? It just feels like this quarter and subsequent to -- sorry, 3Q and kind of subsequent to 3Q is the first time we saw a lot of additional funding to existing buildings? Is it just the demand is so high, that they need money to continue to expand their facilities? Or is it just maybe the natural kind of CapEx requirement to kind of keep the buildings functioning -- or not necessary functioning, but as efficient as possible for their operations? Just any color there would be helpful.

Alan Gold

Analyst

Right. So there's a combination of factors occurring. One, when we enter into the transaction, the initial transaction, the tenants are still finalizing their development plans and -- for the individual projects. And as they go through them, they sometimes come to the situation where they would like more capital provided to fully build out a facility, especially with how quickly some of these state programs are moving and progressing in a positive way. And so with that, we have worked with our growers to amend the leases and provide additional capital, keeping in mind that that does not stop rent from the original -- from any original funding that was started and more than likely -- not more than likely, and most often, the leases are amended and extended and the -- when we do add additional tenant improvements. So you have that. And then you do have the fact that when -- like -- as what's happened in Illinois, the program has changed, not only going from the medical cannabis focus that we're primarily focused on, but these growers also then have the ability to participate in the adult-use program. And when that occurs, there's also additional demand for improvement dollars at our facilities.

Catherine Hastings

Analyst

And just to kind of add-on to that, John, many of our facilities do have expansion capacity within the buildings as well, especially when a new license -- when a new program rolls out in a state, the operators will get up and running within a portion of the building that supports that market. But then as that market continues to grow and add on, as Alan was indicating, they're able to grow into different portions of the building and add infrastructure which we support through the amendment tenant improvement.

Operator

Operator

[Operator Instructions].

Paul Smithers

Analyst

All right. It appears, operator, that there are no more questions. So with that, we'd certainly like to thank all our stakeholders for their support. And I'd love to thank the team for just a fantastic quarter. And thank you all for your hard and dedicated work. With that, we'll sign off. Thank you, operator.

Operator

Operator

And we thank you, sir, also and to the rest of the management team for your time. Again, the conference call is now concluded. At this time, you may disconnect your lines. Thank you again, everyone, take care, and have a great day.